Insightful analysis and commentary for the US and global equity investor
Contributors: Douglas McIntyre Jon C. Ogg

Previous Posts

Tuesday, September 26, 2006

Pre-Market Stock Notes (Sept. 26, 2006)

(AKS) AK Steel union workers rejected their new contract offers.
(AMSF) Amerisafe filed to sell 7.9 million shares of common stock.
(ANGO) Angiodynamics $0.12 EPS vs $0.10e.
(ARII) American Railcar Industries announces new orders to manufacture 1,000 tank railcars to American Railcar Leasing LLC.
(ARNA) Arena was given notice by Merck (MRK) that it was withdrawing from its atherosclerosis study, although it will continue evaluating the compound for other ailments; stock down 7%.
(AVID) Avid tech lowered guidance.
(BLTI) Biolase gets new laser pulse tech patent.
(CECO) CareerEducation CEo is stepping down.
(CEPH) Cephalon gets FDA approval for Fentora for cancer pain management.
(ENMD) EntreMed began Phase 1 study with its clinical-stage drug candidate MKC-1.
(EPCT) Epicept announced positive phase I studies with MYGN and will proceed to Phase II.
(EYE) Advanced Medical Optics lowered guidance.
(HLTH) Emdeon announced 52% majority stake sale of its business services unit.
(IMMC) Immunicon announced that they met the primary and secondary endpoints associated with its pivotal clinical trial in metastatic colorectal cancer.
(IPX) Interpool raised its annual dividend rate.
(JNJ) J&J's Cordis receives FDA approval to mkt Precise Nitinol Stent for clogged neck arteries.
(KFX) KFX is restucturing by naming its CEO to replace the chairman, announced a name change to Evergreen Energy as of September 29, 2006.
(LB) LaBarge awarded $8Million pact from Raytheon for Tomahawk missile. program.
(LEN) Lennar lowered guidance.
(LOW) Lowe's said current sales are below trend expectations.
(MERX) Merix stock down 20% after lowering EPS guidance.
(NSTK) Nastech Pharma was awarded a $1.9 million National Inst. of Health grant.
(NTBK) Net.Bank put guidance at lower end of range and said additional downside is possible.
(PDII) PDI was notified that GlaxoSmithkline will not renew its contract sales agreement after December 31, 2006; represented $65 million to $70 million of annual sales.
(PMCS) PMC-Sierra lowered guidance; stock down 7% pre-market.
(PNR) Pentair lowered guidance, names new president and COO.
(PRGO) Perrigo gets FDA ok for OTC Famotidine tablets.
(QGLY) Quigley Corp following positive data showing QR-333 to be safe; to proceed with Phase IIb clinical trials.
(SIRI) Sirius introduced its new Stiletto 100 radio.
(SRR) Stride Rite $0.24 EPS vs $0.23e.
(TEVA) Teva hosts an analyst day for its branded drug program.
(VXGN) Vaxgen filed its restated 2003 annual report.

Cramer positive again on Time Warner (TWX) and said it isn't too late to buy as it is a straight shot to $26.00.

S&P INDEX CHANGES: WU-Western Union replacing ANDW-Andrew in S&P 500 Index as of FRI SEPT 29 close. ANDW replacing Cabot Micro-CCMP in S&P MID CAP 400 Index. Cabor Micro-CCMP moving down to replace BFT in S&P Small Cap 600 Index. IRC-Inland Real Estate replaces maverick Tube-MVK in S&P Small Cap 600 Index as of close on MON OCT 2. WEN-Wendy's staying in S&P 500 Index, but Tim Horton (THI) will "not" be added to the S&P Index at this time

Powered by Blogger